杨 玉, 周欢娣, 薛晓英, et al. The role and mechanism ofNRAGEin radioresistance of human esophageal cancer cells[J]. China Oncology, 2020, 30(1): 41-48. DOI: 10.19401/j.cnki.1007-3639.2020.01.005.
The role and mechanism ofNRAGEin radioresistance of human esophageal cancer cells
Background and purpose: Esophageal cancer is one of the most common malignant tumors threatening human life and health worldwide. The annual incidence of esophageal cancer in China accounts for more than 50 percent of cases around the world
and squamous cell carcinoma is the most common type. Radiotherapy is one of the three main treatments for malignant tumors
but radioresistance could result in radiotherapy failure. Neurotrophin receptor-interacting MAGE homolog (NRAGE) expression in esophageal carcinoma resistance cell line TE13R120 is significantly higher than that in parental cell line TE13. Moreover
the change of NRAGE subcellular localization might be involved in the formation of radioresistance of esophageal cancer cells. In the present study
we established the esophageal cancer cell line Eca109 stably expressing NRAGE gene using gene transfection technology
then further analyzed the relationship between NRAGE gene and the radioresistance of esophageal squamous cancerous cells. Methods: The esophageal cancer cell line stably expressing NRAGE was constructed through gene transfection. Radiosensitivity of cells was detected using colony formation assay. Cell cycle and apoptosis were detected using flow cytometry
and cell migration and invasion capacities were detected using scratch-wound and Transwell assays. In addition
β-catenin expression in cells was detected using real-time fluorescence quantitative polymerase chain reaction (RTFQ-PCR) and Western blot
and t-test or analysis of variance was adopted for determining intergroup difference. Results: The experiments were divided into transfection over-expression group (Eca109/NRAGE group) and blank control group (Eca109 group). The expression level of NRAGE in Eca109/NRAGE cells was markedly higher than that in Eca109 cells (t=29.65
P0.05). After radiation
the radioresistance of Eca109/NRAGE cells was remarkably higher than that in Eca109 cells. Flow cytometry indicated that the proportion of cells at S phase that had the highest resistance to X-rays in Eca109/NRAGE cells was increased
while those at G 2 /M phase with the highest sensitivity to X-rays was decreased. The apoptotic rate of Eca109/NRAGE cells was lower than that of Eca109 cells (t=3.268
P0.05). Moreover
the Eca109/ NRAGE cells showed higher migration and invasion capacities compared with Eca109 cells. Results of RTFQ-PCR and Western blot suggested that
the β-catenin mRNA expression and protein levels in Eca109/NRAGE cells were notably higher than those in Eca109 cells (t=15.87
P0.05). Conclusion: Over-expression of NRAGE is involved in the formation of radioresistance of ca109 cells
which changes the cell cycle distribution and apoptosis
affects the cell migration and invasion capacities
and may influence the radiosensitivity of esophageal cancer cells. Such effect may be related to the activation of the Wnt/β-catenin signal transduction pathway.
Analysis of pathological remission degree and influencing factors of radical surgery after neoadjuvant immunotherapy combined with chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
Consistency analysis of PD-L1 immunohistochemistry antibodies in esophageal squamous cell carcinoma
SRSF1 promotes proliferation, invasion and migration of esophageal squamous cell carcinoma Eca9706 cells by regulating VEGFA mRNA alternative splicing
miR-203a-3p inhibits cell proliferation and invasion of esophageal squamous cell carcinoma by targeting GATA6
Expression of CCL26 in esophageal squamous cell carcinoma tissues and its clinical significance
Related Author
Daiyuan MA
Kelun GAN
Li ZENG
Yingying MA
Beilei ZENG
Yang PENG
Ziyi LIAO
Yan JIN
Related Institution
Department of Medical Oncology, Affiliated Hospital of Chuanbei Medical College, Nanchong
Department of Pathology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University